Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Bivalent COVID-19 vaccines show higher effectiveness against thromboembolic events

Study finds bivalent mRNA COVID-19 vaccines are more effective than monovalent vaccines in preventing thromboembolic events in older adults and those with end-stage renal disease.

14 Jan 2024

JN.1 variant's spread not due to enhanced immune escape, study suggests

Study finds the JN.1 variant of SARS-CoV-2 may not have increased immune escape ability compared to its predecessor BA.2.86, suggesting other factors for its rapid spread.

14 Jan 2024

NHS needs to ramp up non-emergency treatments by 10% to tackle pandemic backlog

Analysis in The Lancet reveals the NHS must treat at least 10% more non-emergency cases monthly to reduce the pandemic-induced backlog, with over 7.2 million referrals pending as of October 2022.

13 Jan 2024

New study reveals higher mortality risk in COVID-19 patients with newly-diagnosed atrial fibrillation

The incidence and prognosis of newly diagnosed AF in patients hospitalized due to SARS-CoV-2.

12 Jan 2024

Going green reduces COVID risk: Plant-based diets slash risk by up to 41%

Study finds plant-based diets reduce COVID-19 risk by 39-41% compared to meat-based diets, also associated with healthier BMI and lower obesity rates.

11 Jan 2024

Study shows lasting T-cell immunity in healthcare workers against SARS-CoV-2 variants

Study reveals robust memory T-cell responses to SARS-CoV-2 in healthcare workers over 1.5 years post-Omicron, suggesting durable immunity against highly mutated variants.

11 Jan 2024

A universal coronavirus vaccine could provide substantial health and economic benefits

What if scientists had developed a universal coronavirus vaccine in the years prior to 2020 so that it was available at the start of the COVID-19 pandemic?

11 Jan 2024

BNT162b2 vaccine effectiveness in preventing SARS-CoV-2 infection and severe disease

The BNT162b2 vaccine’s effectiveness in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

11 Jan 2024

Phylogenomic analysis to generate early warning signs for COVID-19 waves

The Transmission Fitness Polymorphism (TFP) scanner analysis pipeline to detect severe acute respiratory syndrome coronavirus 2.

11 Jan 2024

Research reveals COVID-19's lasting impact on brain function and structure

Study investigates post-COVID-19 cognitive defects, finding that SARS-CoV-2 infections are linked to brain injury markers and reduced cingulate cortex volume, with corticosteroids offering some cognitive protection.

10 Jan 2024

Study shows engineered antibodies significantly boost Omicron neutralization

Researchers engineered IgA antibodies from IgG monoclonals, enhancing neutralization against Omicron by up to 75-fold and offering protection in mice models.

10 Jan 2024

Pangolins' genetic makeup linked to increased coronavirus susceptibility

Research reveals pangolins' vulnerability to coronavirus due to innate immune gene pseudogenization, impacting their antiviral response.

10 Jan 2024

Research reveals how light can help destroy infectious coronavirus particles

New research has revealed how light can be used to destroy infectious coronavirus particles that contaminate surfaces.

10 Jan 2024

Sickle cell patients lag behind in COVID vaccination despite higher risks

Despite the fact that people with sickle cell disease have a much higher risk of serious illness or death if they develop COVID-19, a new study shows they're also much less likely than those without sickle cell disease to have gotten vaccinated against coronavirus.

10 Jan 2024

Pandemic impact: Significant rise in sleep disturbances among children and adolescents worldwide

The global prevalence of sleep disturbances in children and adolescents during the COVID-19 pandemic.

10 Jan 2024

New Omicron subvariants test vaccine limits, reveal unique infection challenges

Study reveals that the Omicron subvariants BA.2.86 and FLip show unique mutations and infectivity profiles, with BA.2.86 being highly infectious and resistant to most conventional antibodies, underscoring the need for updated vaccines.

9 Jan 2024

MADE-up or real? Review debunks severity of mask-associated dry eye syndrome

A review in the journal Eye finds that prolonged face mask use during the COVID-19 pandemic may cause mild ocular irritation, but serious eye complications are unlikely.

9 Jan 2024

How does religion impact vaccination coverage?

The effect of religious attitudes on real-world vaccination uptake.

9 Jan 2024

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Recent study reveals nirmatrelvir treatment during acute COVID-19 does not lower the risk of post-acute COVID-19 symptoms, nor is it associated with symptomatic rebound.

8 Jan 2024

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.

8 Jan 2024